皓宸医疗(002622)披露控股孙公司收到法院传票及《民事裁定书》公告,11月03日股价上涨3.9%

Core Viewpoint - Haocen Medical (002622) has experienced a stock price increase of 3.9% to 3.46 CNY, with a total market capitalization of 2.906 billion CNY as of November 3, 2025. The company faces a legal dispute regarding the transfer of shares in its subsidiary, Delun Medical, which may pose operational risks despite not directly impacting current or future profits [1]. Group 1 - As of November 3, 2025, Haocen Medical's stock closed at 3.46 CNY, up 3.9% from the previous trading day, with a total market value of 2.906 billion CNY [1]. - The stock opened at 3.33 CNY, reached a high of 3.5 CNY, and a low of 3.31 CNY, with a trading volume of 1.58 billion CNY and a turnover rate of 5.53% [1]. - The company announced that it received a legal document from the Jilin City Chuanming District People's Court regarding a dispute over the revocation of share transfer rights [1]. Group 2 - The lawsuit involves Zhejiang Zheba Xianhu Enterprise Management Partnership (Limited Partnership) as the plaintiff, with Haocen Medical, its wholly-owned subsidiary Zhiyu Medical, and its controlling subsidiary Delun Medical as defendants [1]. - The court has ruled to freeze 51% of Delun Medical's shares held by Zhiyu Medical, corresponding to an investment amount of 26.52 million CNY, with a freeze period of two years [1]. - Delun Medical accounted for 89.78% of the company's total revenue in 2024, indicating its significant role in the company's financial performance [1].